Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities

Interferon in the treatment of chronic hepatitis C: a drug caught between past and future

(2011) Elena Vezali et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Advances in hepatitis C virus vaccines, part one: advances in basic knowledge for hepatitis C virus vaccine design

(2011) Farzin Roohvand et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies

(2011) Jenny Peters et al.   Human vaccines & immunotherapeutics

Cross-Talk between Programmed Death-1 and Suppressor of Cytokine Signaling-1 in Inhibition of IL-12 Production by Monocytes/Macrophages in Hepatitis C Virus Infection

(2011) Y. Zhang et al.   JOURNAL OF IMMUNOLOGY

Enhanced and Sustained CD8+ T Cell Responses with an Adenoviral Vector-Based Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain

(2011) M. Mikkelsen et al.   JOURNAL OF IMMUNOLOGY

Universal peptide vaccines – Optimal peptide vaccine design based on viral sequence conservation

(2011) Nora C. Toussaint et al.   VACCINE

Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice

(2011) Jie Cao et al.   VACCINE

Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice

(2011) Marloes A. Naarding et al.   VACCINE

Protective Efficacy of Serially Up-Ranked Subdominant CD8+ T Cell Epitopes against Virus Challenges

(2011) Eung-Jun Im et al.   PLoS Pathogens

Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers

(2010) Neeraj Mishra et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers

(2010) Debbie Drane et al.   Human vaccines & immunotherapeutics

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

(2010) Eric J. Gowans et al.   JOURNAL OF HEPATOLOGY

In vitro stability of Cucumber mosaic virus nanoparticles carrying a Hepatitis C virus-derived epitope under simulated gastrointestinal conditions and in vivo efficacy of an edible vaccine

(2010) M. Nuzzaci et al.   JOURNAL OF VIROLOGICAL METHODS

Polytope DNA Vaccine Development Against Hepatitis C Virus: A Streamlined Approach from In Silico Design to In Vitro and Primary In Vivo Analyses in BALB/c Mice

(2010) Arash Memarnejadian et al.   PROTEIN AND PEPTIDE LETTERS

Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine

(2010) Christa Firbas et al.   VACCINE

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

(2010) Sharon E. Frey et al.   VACCINE

Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles

(2009) Shigeru Yutani et al.   CANCER SCIENCE

Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine

(2009) Arash Memarnejadian et al.   CELLULAR IMMUNOLOGY

Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine

(2009) Christine Hartoonian et al.   CYTOKINE

Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination

(2009) Marlen Castellanos et al.   JOURNAL OF GENE MEDICINE

Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies

(2009) Romuald Patient et al.   New Biotechnology

ISCOMs and ISCOMATRIX™

(2009) Hong-Xiang Sun et al.   VACCINE

Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C

(2009) Heiner Wedemeyer et al.   VACCINE

T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation

(2009) I. Zubkova et al.   VACCINE

Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice

(2009) Arash Arashkia et al.   VIRUS GENES

New views on immunopotentiators in modern vaccines

(2008) Virgil EJC Schijns et al.   Expert Review of Vaccines

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

(2008) Christoph S. Klade et al.   GASTROENTEROLOGY

61 FACTORS INFLUENCING PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS OF THE 3-YEAR T2S-918-HCV STUDY WITH HCVE1 THERAPEUTIC VACCINATION

(2008) H. Wedemeyer et al.   JOURNAL OF HEPATOLOGY

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial

(2008) L. Alvarez-Lajonchere et al.   JOURNAL OF VIRAL HEPATITIS

Induction of Broad CD4+ and CD8+ T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5

(2008) Y. Lin et al.   JOURNAL OF VIROLOGY

Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants

(2008) Qi Qiu et al.   VACCINE

A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection

(2008) Brendon Y. Chua et al.   VACCINE

Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073

(2008) P. Fytili et al.   VACCINE

A vector-based minigene vaccine approach results in strong induction of T-cell responses specific of hepatitis C virus

(2008) Perrine Martin et al.   VACCINE